Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Puma Biotechnology Inc (PBYI)

  • Event
  • Aug. 02, 2022, 20:47 UTC
  • 13
  • 1 comments

(99% Neutral) PUMA BIOTECHNOLOGY, INC. (PBYI) Announces New Board Appointment

Comment Full text

Apellis Pharmaceuticals Inc (APLS)

  • Event
  • Aug. 02, 2022, 20:38 UTC
  • 14
  • 1 comments

(99% Neutral) Apellis Pharmaceuticals, Inc. (APLS) Announces Business Combination

Comment Full text

Veracyte Inc (VCYT)

  • Event
  • Aug. 02, 2022, 20:15 UTC
  • 14
  • 1 comments

(30% Negative) VERACYTE, INC. (VCYT) Reports Q3 2022 Financial Results

Comment Full text

Ligand Pharmaceuticals Incorporated (LGND)

  • Event
  • Aug. 02, 2022, 20:10 UTC
  • 15
  • 1 comments

(99% Neutral) LIGAND PHARMACEUTICALS INC (LGND) Announces Executive Changes

Comment Full text

Gilead Sciences Inc (GILD)

  • Event
  • Aug. 02, 2022, 20:05 UTC
  • 14
  • 1 comments

(30% Negative) GILEAD SCIENCES, INC. (GILD) Reports Q3 2022 Financial Results

Comment Full text

Genmab (GMAB)

  • Event
  • Aug. 02, 2022, 19:08 UTC
  • 11
  • 1 comments

(99% Neutral) Genmab (GMAB) Announces Clinical Development Update (Form 6-K)

Comment Full text

AC Immune Ltd (ACIU)

  • Event
  • Aug. 02, 2022, 15:12 UTC
  • 11
  • 1 comments

(90% Positive) AC Immune Ltd (ACIU) Announces Clinical Development Update (Form 6-K)

Comment Full text

Gilead Sciences Inc (GILD)

  • Event
  • Aug. 02, 2022, 13:03 UTC
  • 94
  • 0 comments

Gilead - Q2 2022 Presentation

Comment Full text

C4 Therapeutics Inc (CCCC)

  • Event
  • Aug. 02, 2022, 12:33 UTC
  • 14
  • 1 comments

(90% Positive) C4 THERAPEUTICS, INC. (CCCC) Provides Update on Development for Support of Successful Product Launches – –Dr

Comment Full text

Rallybio Corporation (RLYB)

  • Event
  • Aug. 02, 2022, 12:30 UTC
  • 14
  • 1 comments

(50% Neutral) RALLYBIO CORPORATION (RLYB) Announces Clinical Development Update

Comment Full text
  • Previous
  • 142
  • 143
  • 144
  • 145
  • 146
  • Next

Search

News categories

  • Technical Exchange News(10877)
  • Event(2261)
  • SEC News(189391)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124578)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin